Evidence map›Paper›PMID 34957111›Full record

ArticleFrontiers in cell and developmental biology2021

Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells.

Irfan Khan, Marcel O Schmidt, Bhaskar Kallakury, Sidharth Jain, Shaunt Mehdikhani, Moshe Levi, Margarida Mendonca, William Welch, Anna T Riegel, Christopher S Wilcox and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Cellular senescence and kidney aging.Clinical science (London, England : 1979) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Irfan KhanLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Marcel O SchmidtLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Bhaskar KallakuryDivision of Pathology, Georgetown University, Washington, DC, United States.
Sidharth JainLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Shaunt MehdikhaniLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Moshe LeviDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, United States.
Margarida MendoncaDivision of Nephrology and Hypertension, Kidney, and Vascular Research Center, Georgetown University, Washington, DC, United States.
William WelchDivision of Nephrology and Hypertension, Kidney, and Vascular Research Center, Georgetown University, Washington, DC, United States.
Anna T RiegelLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Christopher S WilcoxDivision of Nephrology and Hypertension, Kidney, and Vascular Research Center, Georgetown University, Washington, DC, United States.
Anton WellsteinLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States.
Georgetown University · USGeorgetown University Medical Center · US

Funding

TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Pharmacological Sciences Training Program (PSTP)T32GM142520 · NIGMS · GEORGETOWN UNIVERSITY · PI Patrick Alexander Forcelli, Anton Wellstein · 2022 to 2026
$1.3M
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapyF30CA243357 · NCI · GEORGETOWN UNIVERSITY · PI KHAN, IRFAN · 2019 to 2023
$221k
NCI NIH HHS F30 CA243357NCI NIH HHS T32 CA009686NIGMS NIH HHS T32 GM142520
6 · The paper itself

Abstract

Angiotensin II can cause oxidative stress and increased blood pressure that result in long term cardiovascular pathologies. Here we evaluated the contribution of cellular senescence to the effect of chronic exposure to low dose angiotensin II in a model that mimics long term tissue damage. We utilized the INK-ATTAC (p16

Indexed as

angiotensin IIendothelial cellsINK-ATTACsenescencevon Willebrand factor

Identifiers

PMID34957111
PMCPMC8696590
OpenAlexW4200050616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.